• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重与随后心房颤动急诊就诊和住院风险。

Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation.

机构信息

Department of Emergency Medicine, Massachusetts General Hospital, Boston (A.H., T.G., M.K.F., C.A.C., K.H.).

Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY (Y.J.S.).

出版信息

Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006322. doi: 10.1161/CIRCEP.118.006322.

DOI:10.1161/CIRCEP.118.006322
PMID:30354294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7735661/
Abstract

Background Although emerging evidence has suggested the relationship of chronic obstructive pulmonary disease with atrial fibrillation (AF), little is known about whether acute exacerbation of chronic obstructive pulmonary disease (AECOPD) increases the risk of repeated AF-related healthcare utilization. Methods This is a self-controlled case series study using the population-based emergency department (ED) and inpatient databases of 5 US states from 2007 through 2012. Among patients with existing AF, we identified patients with an AECOPD hospitalization and at least 1 ED visit or hospitalization for AF during the observation period. We constructed conditional Poisson regression models to compare the rate of AF-related ED visits or hospitalizations during sequential 90-day periods after the AECOPD hospitalization, with pre-AECOPD days 1 to 90 as the reference. Results We analyzed 944 patients who were hospitalized for AECOPD and had an ED visit or hospitalization for AF during a 450-day period. The median age was 77 years, and 41% were men. Compared with the reference period, the rate of AF-related ED visits or hospitalizations significantly increased in the post-AECOPD days 1 to 90 (7.3 versus 14.1 per 100 person-months; rate ratio, 1.93; 95% CI, 1.63-2.29; P<0.001). Then, the rate decreased to the reference level in the post-AECOPD days 91 to 180 (7.5 per 100 person-months; rate ratio, 1.03; 95% CI, 0.85-1.25; P=0.77) and remained at the reference level during post-AECOPD days 181 to 270 (rate ratio, 0.84; 95% CI, 0.68-1.03; P=0.09) and days 271 to 360 (rate ratio, 0.90; 95% CI, 0.73-1.10; P=0.29). These temporal associations persisted with stratification by age, sex, and season. Conclusions Among patients with existing AF, AECOPD was associated with a higher risk of AF-related ED visit or hospitalization in the first 90-day post-AECOPD period.

摘要

背景

尽管有新的证据表明慢性阻塞性肺疾病(COPD)与心房颤动(AF)有关,但对于 COPD 急性加重(AECOPD)是否会增加反复 AF 相关医疗保健利用的风险知之甚少。

方法

这是一项使用 2007 年至 2012 年 5 个美国州的基于人群的急诊(ED)和住院数据库的自我对照病例系列研究。在存在 AF 的患者中,我们确定了 AECOPD 住院患者和观察期间至少有一次 ED 就诊或 AF 住院的患者。我们构建了条件泊松回归模型,以比较 AECOPD 住院后连续 90 天内 AF 相关 ED 就诊或住院的发生率,以 AECOPD 前 90 天(1-90 天)为参考。

结果

我们分析了 944 名因 AECOPD 住院且在 450 天内因 AF 就诊或住院的患者。中位年龄为 77 岁,41%为男性。与参考期相比,AECOPD 后 1-90 天 AF 相关 ED 就诊或住院的发生率显著增加(每 100 人-月 7.3 次与 14.1 次;发生率比,1.93;95%CI,1.63-2.29;P<0.001)。然后,AECOPD 后 91-180 天的发生率降至参考水平(每 100 人-月 7.5 次;发生率比,1.03;95%CI,0.85-1.25;P=0.77),AECOPD 后 181-270 天(发生率比,0.84;95%CI,0.68-1.03;P=0.09)和 271-360 天(发生率比,0.90;95%CI,0.73-1.10;P=0.29)的发生率保持在参考水平。这些时间关联在按年龄、性别和季节分层时仍然存在。

结论

在存在 AF 的患者中,AECOPD 与 AECOPD 后第一个 90 天内 AF 相关 ED 就诊或住院的风险增加有关。

相似文献

1
Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Subsequent Risk of Emergency Department Visits and Hospitalizations for Atrial Fibrillation.慢性阻塞性肺疾病急性加重与随后心房颤动急诊就诊和住院风险。
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006322. doi: 10.1161/CIRCEP.118.006322.
2
Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease.经常利用急诊部门治疗慢性阻塞性肺疾病的急性加重。
Respir Res. 2014 Apr 10;15(1):40. doi: 10.1186/1465-9921-15-40.
3
Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments, 2010-2018.2010-2018 年美国急诊科慢性阻塞性肺疾病急性加重。
BMC Pulm Med. 2023 Jun 20;23(1):217. doi: 10.1186/s12890-023-02518-0.
4
National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005.1993 - 2005年慢性阻塞性肺疾病急性加重期急诊就诊情况的全国性研究
Acad Emerg Med. 2008 Dec;15(12):1275-83. doi: 10.1111/j.1553-2712.2008.00284.x. Epub 2008 Oct 25.
5
Prevalence and Associated Factors of Paroxysmal Atrial Fibrillation and Atrial Arrhythmias During Hospitalizations for Exacerbation of COPD.COPD 加重期住院患者阵发性心房颤动和心律失常的患病率及相关因素。
Int J Chron Obstruct Pulmon Dis. 2024 Sep 4;19:1989-2000. doi: 10.2147/COPD.S473289. eCollection 2024.
6
Effect of Bariatric Surgery on Emergency Department Visits and Hospitalizations for Atrial Fibrillation.减肥手术对心房颤动患者急诊科就诊及住院情况的影响。
Am J Cardiol. 2017 Sep 15;120(6):947-952. doi: 10.1016/j.amjcard.2017.06.026. Epub 2017 Jun 27.
7
Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Are There Significant Differences Between Hospitalized and Emergency Department Patients?慢性阻塞性肺疾病急性加重:住院患者和急诊科患者之间有显著差异吗?
Int J Chron Obstruct Pulmon Dis. 2024 Jan 16;19:133-138. doi: 10.2147/COPD.S447477. eCollection 2024.
8
Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD.COPD 急性加重后急性心血管事件的发生率。
J Gen Intern Med. 2018 Sep;33(9):1461-1468. doi: 10.1007/s11606-018-4518-3. Epub 2018 Jun 8.
9
Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014.美国因房颤急诊就诊:2007 年至 2014 年住院率及经济负担的趋势。
J Am Heart Assoc. 2018 Jul 20;7(15):e009024. doi: 10.1161/JAHA.118.009024.
10
Emergency department case volume and patient outcomes in acute exacerbations of chronic obstructive pulmonary disease.急诊科慢性阻塞性肺疾病急性加重患者的病例量与患者结局。
Acad Emerg Med. 2012 Jun;19(6):656-63. doi: 10.1111/j.1553-2712.2012.01363.x.

引用本文的文献

1
Structure of Comorbidities and Causes of Death in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.心房颤动合并慢性阻塞性肺疾病患者的共病结构及死亡原因
J Clin Med. 2025 Jul 16;14(14):5045. doi: 10.3390/jcm14145045.
2
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
3
Structured Cardiac Assessment and Treatment Following Exacerbations of COPD (SCATECOPD): A Pilot Randomised Controlled Trial.慢性阻塞性肺疾病急性加重后结构化心脏评估与治疗(SCATECOPD):一项试点随机对照试验
Biomedicines. 2025 Mar 7;13(3):658. doi: 10.3390/biomedicines13030658.
4
Exacerbating the Problem: COPD and Atrial Fibrillation.问题加剧:慢性阻塞性肺疾病与心房颤动
Am J Respir Crit Care Med. 2025 Mar 12;211(5):695-7. doi: 10.1164/rccm.202501-0229ED.
5
Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.慢性阻塞性肺疾病稳定期和加重期患者心血管风险的时间动态:机制与意义综述。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 10;19:2259-2271. doi: 10.2147/COPD.S466280. eCollection 2024.
6
Detrimental Impact of Atrial Fibrillation among Patients Hospitalized for Acute Exacerbation of COPD: Results of a Population-Based Study in Spain from 2016 to 2021.慢性阻塞性肺疾病急性加重住院患者中房颤的有害影响:一项基于2016年至2021年西班牙人群研究的结果
J Clin Med. 2024 May 9;13(10):2803. doi: 10.3390/jcm13102803.
7
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control study.COPD 加重后 30 天内与非致命性心力衰竭和心房颤动或扑动相关的因素:一项嵌套病例对照研究。
BMC Pulm Med. 2024 May 4;24(1):221. doi: 10.1186/s12890-024-03035-4.
8
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.亚洲心房颤动合并慢性阻塞性肺疾病患者的死亡和心血管事件风险:来自前瞻性 APHRS 注册研究的报告。
J Am Heart Assoc. 2024 Apr 2;13(7):e032785. doi: 10.1161/JAHA.123.032785. Epub 2024 Mar 27.
9
Atrial fibrillation: comorbidities, lifestyle, and patient factors.心房颤动:合并症、生活方式及患者因素。
Lancet Reg Health Eur. 2024 Feb 1;37:100784. doi: 10.1016/j.lanepe.2023.100784. eCollection 2024 Feb.
10
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.慢性阻塞性肺疾病急性加重后非致命性心血管事件的时间风险:一项基于人群的研究。
Am J Respir Crit Care Med. 2024 Apr 15;209(8):960-972. doi: 10.1164/rccm.202307-1122OC.

本文引用的文献

1
Association of Obesity With Severity of Heart Failure Exacerbation: A Population-Based Study.肥胖与心力衰竭恶化严重程度的关联:基于人群的研究。
J Am Heart Assoc. 2018 Mar 15;7(6):e008243. doi: 10.1161/JAHA.117.008243.
2
Sex and racial/ethnic differences in the reason for 30-day readmission after COPD hospitalization.慢性阻塞性肺疾病(COPD)住院 30 天后再入院的原因存在性别和种族/民族差异。
Respir Med. 2017 Oct;131:6-10. doi: 10.1016/j.rmed.2017.07.056. Epub 2017 Jul 25.
3
Seasonal trends in atrial fibrillation episodes and physical activity collected daily with a remote monitoring system for cardiac implantable electronic devices.使用心脏植入式电子设备远程监测系统每日收集的房颤发作和身体活动的季节性趋势。
Int J Cardiol. 2017 May 1;234:48-52. doi: 10.1016/j.ijcard.2017.02.074. Epub 2017 Feb 22.
4
Self controlled case series methods: an alternative to standard epidemiological study designs.自我对照病例系列方法:标准流行病学研究设计的替代方法
BMJ. 2016 Sep 12;354:i4515. doi: 10.1136/bmj.i4515.
5
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.非瓣膜性心房颤动抗凝治疗患者的死亡原因及全因死亡率预测因素:来自ROCKET AF研究的数据
J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.
6
Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation: Population-Based, Self-Controlled Series.减重手术与心力衰竭恶化急诊就诊和住院:基于人群的自身对照系列研究。
J Am Coll Cardiol. 2016 Mar 1;67(8):895-903. doi: 10.1016/j.jacc.2015.12.016.
7
Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.心房颤动患者的慢性阻塞性肺疾病:来自ARISTOTLE试验的见解。
Int J Cardiol. 2016 Jan 1;202:589-94. doi: 10.1016/j.ijcard.2015.09.062. Epub 2015 Sep 25.
8
A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.罗氟司特的一项随机、安慰剂对照试验。对慢性阻塞性肺疾病中脯氨酸 - 甘氨酸 - 脯氨酸及中性粒细胞炎症的影响
Am J Respir Crit Care Med. 2015 Oct 15;192(8):934-42. doi: 10.1164/rccm.201503-0543OC.
9
Atrial fibrillation in the acute, hypercapnic exacerbations of COPD.慢性阻塞性肺疾病急性高碳酸血症加重期的心房颤动
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2908-17.
10
An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease.异常的白三烯A4水解酶-脯氨酸-甘氨酸-脯氨酸途径在慢性阻塞性肺疾病发病机制中的作用
Am J Respir Crit Care Med. 2014 Jul 1;190(1):51-61. doi: 10.1164/rccm.201401-0145OC.